최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기The American journal of hospice & palliative care, v.17 no.6, 2000년, pp.407 - 413
Pappagallo, Marco (Comprehensive Pain Treatment Center, New York University School of Medicine, New York, New York) , Dickerson, E. Duke (Oxford International Centre of Palliative Care, Ohio Pain Initiative, Columbus, Ohio) , Hulka, Scott (Roxane Laboratories, Columbus, Ohio)
초록이 없습니다.
American Journal of Hospital Pharmacy Lipman AG S7 47 58 1990
Ross, Fraser B, Smith, Maree T. The intrinsic antinociceptive effects of oxycodone appear to be κ-opioid receptor mediated. Pain, vol.73, no.2, 151-157.
Ross, F.B., Wallis, S.C., Smith, M.T.. Co-administration of sub-antinociceptive doses of oxycodone and morphine produces marked antinociceptive synergy with reduced CNS side-effects in rats. Pain, vol.84, no.2, 421-428.
Coyle, N., Adelhardt, J., Foley, K.M., Portenoy, R.K.. Character of terminal illness in the advanced cancer patient: Pain and other symptoms during the last four weeks of life. Journal of pain and symptom management, vol.5, no.2, 83-93.
Fainsinger, Robin, Miller, Melvin J., Bruera, Eduardo, Hanson, John, Maceachern, Tara. Symptom Control during the Last Week of Life on a Palliative Care Unit. Journal of palliative care, vol.7, no.1, 5-11.
Management of Cancer Pain US Department of Health and Human Services 1994
Journal of Pain and Symptom Management Mercadante S 1999
Portenoy, Russell K, Lesage, Pauline. Management of cancer pain. The Lancet, vol.353, no.9165, 1695-1700.
Heiskanen, Tarja, Kalso, Eija. Controlled-release oxycodone and morphine in cancer related pain. Pain, vol.73, no.1, 37-45.
Portenoy, R.K., Hagen, N.A.. Breakthrough pain: definition, prevalence and characteristics. Pain, vol.41, no.3, 273-281.
Oncology Simmonds MA 1103 13 8 1999
Fine, Perry G, Busch, Michael A. Characterization of Breakthrough Pain by Hospice Patients and Their Caregivers. Journal of pain and symptom management, vol.16, no.3, 179-183.
Portenoy RK, Hagen NA: op. cit.
Oncology Patt RB 1035 12 7 1998
10.1002/1097-0142(19931201)72:11+<3393::AID-CNCR2820721606>3.0.CO;2-O
Glare, P A, Walsh, T D. Dose-ranging study of oxycodone for chronic pain in advanced cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol.11, no.5, 973-978.
Patt RB: op. cit.
Simmonds MA: op. cit.
Analgesic Ladder for the Management of Cancer Pain Portenoy RK 1995
Cancer Pain Relief World Health Organization 1986
Cherny, Nathan I.. Opioid Analgesics : Comparative Features and Prescribing Guidelines. Drugs, vol.51, no.5, 713-737.
Palliative Care Formulary Twycross R 1998
Ripamonti, C, Groff, L, Brunelli, C, Polastri, D, Stavrakis, A, De Conno, F. Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio?. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol.16, no.10, 3216-3221.
Zhukovsky, Donna S, Walsh, Declan, Doona, Marie. The Relative Potency between High Dose Oral Oxycodone and Intravenous Morphine : A Case Illustration. Journal of pain and symptom management, vol.18, no.1, 53-55.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.